Compare INVA & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVA | DFH |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2004 | 2021 |
| Metric | INVA | DFH |
|---|---|---|
| Price | $19.64 | $17.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $36.80 | $26.00 |
| AVG Volume (30 Days) | ★ 940.8K | 442.0K |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.96 | N/A |
| EPS | 1.52 | ★ 2.84 |
| Revenue | $388,521,000.00 | ★ $4,671,814,000.00 |
| Revenue This Year | $13.23 | N/A |
| Revenue Next Year | $8.58 | $1.86 |
| P/E Ratio | $12.81 | ★ $5.97 |
| Revenue Growth | 10.14 | ★ 15.98 |
| 52 Week Low | $16.52 | $16.59 |
| 52 Week High | $22.76 | $31.50 |
| Indicator | INVA | DFH |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 43.39 |
| Support Level | $19.26 | $16.59 |
| Resistance Level | $20.23 | $17.64 |
| Average True Range (ATR) | 0.46 | 0.64 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 45.54 | 33.66 |
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.